215 related articles for article (PubMed ID: 27750201)
1. Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives.
Ghiano DG; de la Iglesia A; Liu N; Tonge PJ; Morbidoni HR; Labadie GR
Eur J Med Chem; 2017 Jan; 125():842-852. PubMed ID: 27750201
[TBL] [Abstract][Full Text] [Related]
2. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
3. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
5. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
7. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
Shaikh MH; Subhedar DD; Arkile M; Khedkar VM; Jadhav N; Sarkar D; Shingate BB
Bioorg Med Chem Lett; 2016 Jan; 26(2):561-569. PubMed ID: 26642768
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
11. Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
Li Z; Bai X; Deng Q; Zhang G; Zhou L; Liu Y; Wang J; Wang Y
Bioorg Med Chem; 2017 Jan; 25(1):213-220. PubMed ID: 27810439
[TBL] [Abstract][Full Text] [Related]
12. Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages.
Pulipati L; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Jun; 26(11):2649-54. PubMed ID: 27101894
[TBL] [Abstract][Full Text] [Related]
13. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.
Ramprasad J; Kumar Sthalam V; Linga Murthy Thampunuri R; Bhukya S; Ummanni R; Balasubramanian S; Pabbaraja S
Bioorg Med Chem Lett; 2019 Oct; 29(20):126671. PubMed ID: 31526604
[TBL] [Abstract][Full Text] [Related]
15. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
Aziz Ali A; Gogoi D; Chaliha AK; Buragohain AK; Trivedi P; Saikia PJ; Gehlot PS; Kumar A; Chaturvedi V; Sarma D
Bioorg Med Chem Lett; 2017 Aug; 27(16):3698-3703. PubMed ID: 28712709
[TBL] [Abstract][Full Text] [Related]
17. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
[TBL] [Abstract][Full Text] [Related]
18. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
